Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2017

01-04-2017 | Original Paper

Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review

Authors: Debarchana Ghosh, Archana Krishnan, Britton Gibson, Shan-Estelle Brown, Carl A. Latkin, Frederick L. Altice

Published in: AIDS and Behavior | Issue 4/2017

Login to get access

Abstract

Social network analysis (SNA) and social network-based interventions (SNI) are important analytical tools harnessing peer and family influences critical for HIV prevention and treatment among substance users. While SNA is an effective way to measure social network influences, SNI directly or indirectly involves network members in interventions. Even though these methods have been applied in heterogeneous ways, leading to extensive evidence-based practices, systematic reviews are however, lacking. We searched five bibliographic databases and identified 58 studies involving HIV in substance users that had utilized SNA or SNI as part of their methodology. SNA was used to measure network variables as inputs in statistical/mathematical models in 64 % of studies and only 22 % of studies used SNI. Most studies focused on HIV prevention and few addressed diagnosis (k = 4), care linkage and retention (k = 5), ART adherence (k = 2), and viral suppression (k = 1). This systematic review highlights both the advantages and disadvantages of social network approaches for HIV prevention and treatment and gaps in its use for HIV care continuum.
Literature
1.
2.
3.
Cook C, Bridge J, McLean S, Phelan M, Barrett D. The funding crisis for harm reduction: donor retreat, government neglect and the way forward. London: International Harm Reduction Association; 2014.
4.
Stein J, Newcomb M, Bentler PM. An 8-year study of multiplt influences on drug use consequences. J Pers Soc Psychol. 1987;53:1094–105.CrossRefPubMed
5.
Krishnan A, Brown SE, Ghani M, Khan F, Kamarulzaman A, Altice FL. Pre-treatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: a mixed methods approach. Subst Abus. 2016;. doi:10.​1080/​08897077.​2016.​1146648.PubMed
6.
Wu J, Witkiewitz K. Network support for drinking: an application of multiple groups growth mixture modeling to examine client-treatment matching. J Stud Alcohol. 2008;69(1):21–9.CrossRef
7.
Wu LT, Ling W, Burchett B, Blazer DG, Yang C, Pan JJ, et al. Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug Alcohol Depend. 2011;118(2–3):186–93.CrossRefPubMedPubMedCentral
8.
Kimbrough LW, Fisher HE, Jones KT, Johnson W, Thadiparthi S, Dooley S. Accessing social networks with high rates of undiagnosed HIV infection: the social networks demonstration project. Am J Public Health. 2009;99(6):1093–9.CrossRefPubMedPubMedCentral
9.
Gorbach PM, Sopheab H, Phalla T, Leng HB, Mills S, Bennett A, et al. Sexual bridging by Cambodian men—potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis. 2000;27(6):320–6.CrossRefPubMed
10.
Jenness SM, Neaigus A, Hagan H, Murrill CS, Wendel T. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. Aids Patient Care STDs. 2010;24(3):175–81.CrossRefPubMed
11.
Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMed
12.
Latkin CA, Mandell W, Vlahov D. The relationship between risk networks’ patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study. Drug Alcohol Depend. 1996;42(3):175–81.CrossRefPubMed
13.
El-Bassel N, Chen DR, Cooper D. Social support and social network profiles among women on methadone. Soc Serv Rev. 1998;72(3):379–401.CrossRef
14.
Prentice D, Miller D. Pluralistic ignorance ans alcohol use on campus: some consequences of misperceiving the social norm. J Pers Soc Psychol. 1993;64:243–56.CrossRefPubMed
15.
Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abus. 1993;19(3):251–62.CrossRef
16.
De P, Cox J, Boivin J-F, Platt RW, Jolly AM. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health. 2008;85(1):77–89.CrossRefPubMed
17.
Latkin CA, Davey MA, Hua W. Social context of needle selling in Baltimore, Maryland. Subst Use Misuse. 2006;41(6–7):901–13.CrossRefPubMed
18.
el-Bassel N, Cooper DK, Chen, Schilling RF. Personal social networks and HIV status among women on methadone. AIDS Care. 1998;10(6):735–49.CrossRefPubMed
19.
Gordon AJ, Zrull M. Social networks and recovery: one year after inpatient treatment. J Subst Abuse Treat. 1991;8(3):143–52.CrossRefPubMed
20.
El-Bassel N, Gilbert L, Wu E, Chang M. A social network profile and HIV risk among men on methadone: do social networks matter? J Urban Health. 2006;83(4):602–13.CrossRefPubMedPubMedCentral
21.
Latkin C. A persona network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. NIDA Res Monogr. 1995;151:181–95.PubMed
22.
Neaigus A, Friedman S, Goldstein M, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res Monogr. 1995;151:20–37.PubMed
23.
Friedman S. Promising social network research results and suggestions for a research agenda. NIDA Res Monogr. 1995;151:196–215.PubMed
24.
Neaigus A, Friedman SR, Curtis R, Des Jarlais DC, Furst RT, Jose B, et al. The relevance of drug injectors’ social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38(1):67–78.CrossRefPubMed
25.
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. Am J Commun Psychol. 1996;24(3):341–64.CrossRef
26.
Miller M, Paone D. Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Soc Sci Med. 1998;47(6):765–77.CrossRefPubMed
27.
Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(7 Suppl):S39–45.CrossRefPubMed
28.
Young AM, Jonas AB, Mullins UL, Halgin DS, Havens JR. Network structure and the risk for HIV transmission among rural drug users. AIDS Behav. 2013;17(7):2341–51.CrossRefPubMedPubMedCentral
29.
Friedman SR, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997;87(8):1289–96.CrossRefPubMedPubMedCentral
30.
Gyarmathy VA, Caplinskiene I, Caplinskas S, Latkin CA. Social network structure and HIV infection among injecting drug users in Lithuania: gatekeepers as bridges of infection. AIDS Behav. 2014;18(3):505–10.CrossRefPubMedPubMedCentral
31.
Howard DL, Latkin CA. A bridge over troubled waters: factors associated with non-injection drug users having injection drug-using sex partners. J Acquir Immune Defic Syndr. 2006;42(3):325–30.CrossRefPubMed
32.
Albarracin D, Tannenbaum MB, Glasman LR, Rothman AJ. Modeling structural, dyadic, and individual factors: the inclusion and exclusion model of HIV related behavior. AIDS Behav. 2010;14(Suppl 2):239–49.CrossRefPubMedPubMedCentral
33.
Latkin C, Weeks MR, Glasman L, Galletly C, Albarracin D. A dynamic social systems model for considering structural factors in HIV prevention and detection. AIDS Behav. 2010;14(Suppl 2):222–38.CrossRefPubMedPubMedCentral
34.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral
35.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.CrossRef
36.
Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.CrossRefPubMed
37.
Klovdahl AS, Potterat JJ, Woodhouse DE, Muth JB, Muth SQ, Darrow WW. Social networks and infectious disease: the Colorado Springs Study. Soc Sci Med. 1994;38(1):79–88.CrossRefPubMed
38.
Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D. The relationships between sexual-behavior, alcohol-use, and personal network characteristics among injecting drug-users in Baltimore, Maryland. Sex Transm Dis. 1994;21(3):161–7.CrossRefPubMed
39.
Johnston D, Stall R, Smith K. Reliance by gay men and intravenous-drug-users on friends and family for AIDS-related care. Aids Care-Psychol Socio-Med Aspects AIDS/HIV. 1995;7(3):307–19.CrossRef
40.
Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38(1):1–9.CrossRefPubMed
41.
Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J. Acquir. Immune Defic Syndr Human Retrovirol. 1996;11(5):499–509.CrossRef
42.
Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1–2):41–51.CrossRefPubMed
43.
Broadhead R, Heckathorn D, Weakliem D, Anthony D, Madray H, Mills R, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a Peer-Driven intervention. Public Health Rep. 1998;113(Supplement 1):42–57.PubMedPubMedCentral
44.
Heckathorn D, Broadhead R, Anthony D, Weakliem D. AIDS and social networks: HIV prevention through network mobilization. Sociol Focus. 1998;32:159–79.CrossRef
45.
Ennett ST, Bailey SL, Federman EB. Social network characteristics associated with risky behaviors among runaway and homeless youth. J Health Soc Behav. 1999;40(1):63–78.CrossRefPubMed
46.
Servegev B, Oparina T, Rumyantseva TP, Volkanevskii VL, Broadhead RS, Heckathorn DD, et al. HIV prevention in Yaroslavl, Russia: a peer-driven intervention and needle exchange. J. Drug Issues. 1999;29(4):777–804.CrossRef
47.
Bell DC, Montoya ID, Atkinson JS. Partner concordance in reports of joint risk behaviors. J Acquir Immune Defic Syndr. 2000;25(2):173–81.CrossRefPubMed
48.
Bell DC, Montoya ID, Atkinson JS, Yang S-J. Social networks and forecasting the spread of HIV infection. J Acquir Immune Defic Syndr. 2002;31(2):218–29.CrossRefPubMed
49.
Broadhead RS, Heckathorn DD, Altice FL, van Hulst Y, Carbone M, Friedland GH, et al. Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med. 2002;55(2):235–46.CrossRefPubMed
50.
Friedman SR, Kang SY, Deren S, Robles R, Colon HM, Andia J, et al. Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamon, Puerto Rico. J Psychoact Drugs. 2002;34(4):363–9.CrossRef
51.
Kottiri BJ, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002;30(1):95–104.CrossRefPubMed
52.
Bell DC, Mosier V, Atkinson JS. Protecting oneself from human immunodeficiency virus: are prevention messages being heard? Clin Infect Dis. 2003;37:S433–8.CrossRefPubMed
53.
Latkin CA, Hua W, Forman VL. The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, MD, USA. Int J STD AIDS. 2003;14(11):770–5.CrossRefPubMed
54.
Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.CrossRefPubMed
55.
Knowlton A, Hua W, Latkin C. Social support among HIV positive injection drug users: implications to integrated intervention for HIV positives. AIDS Behav. 2004;8(4):357–63.CrossRefPubMed
56.
Kang SY, Deren S, Andia J, Colon HM, Robles R. Egocentric HIV risk networks among Puerto Rican crack users in New York and in Puerto Rico: impact on sex risk behaviors over time. AIDS Educ Prev. 2005;17(1):53–67.CrossRefPubMed
57.
Knowlton AR, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–92.CrossRefPubMed
58.
Broadhead RS, Volkanevsky VL, Rydanova T, Ryabkova M, Borch C, van Hulst Y, et al. Peer-driven HIV interventions for drug injectors in Russia: first year impact results of a field experiment. Int J Drug Policy. 2006;17(5):379–92.CrossRef
59.
Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.CrossRefPubMed
60.
Friedman SR, Mateu-Gelabert P, Curtis R, Maslow C, Bolyard M, Sandoval M, et al. Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med. 2007;32(6 Suppl):S160–70.CrossRefPubMedPubMedCentral
61.
Miller M, Korves CT, Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care. 2007;19(7):858–65.CrossRefPubMed
62.
Needle R, Kroeger K, Belani H, Achrekar A, Parry CD, Dewing S. Sex, drugs, and HIV: rapid assessment of HIV risk behaviors among street-based drug using sex workers in Durban, South Africa. Soc Sci Med. 2008;67(9):1447–55.CrossRefPubMed
63.
Tobin KE, Latkin CA. An examination of social network characteristics of men who have sex with men who use drugs. Sex Transm Infect. 2008;84(6):420–4.CrossRefPubMedPubMedCentral
64.
Tyler KA. Social network characteristics and risky sexual and drug related behaviors among homeless young adults. Soc Sci Res. 2008;37(2):673–85.CrossRefPubMed
65.
Abramovitz DV, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SDW, El Cuete P. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009;36(12):750–6.CrossRefPubMedPubMedCentral
66.
Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S. Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in Ukraine. J Drug Issues. 2009;39(3):607–25.CrossRef
67.
Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDs. 2009;23(8):603–9.CrossRefPubMed
68.
Sherman SG, Sutcliffe C, Srirojn B, Latkin CA, Aramratanna A, Celentano DD. Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. Soc Sci Med. 2009;68(1):69–79.CrossRefPubMed
69.
Youm Y, Mackesy-Amiti ME, Williams CT, Ouellet LJ. Identifying hidden sexual bridging communities in Chicago. J Urban Health. 2009;86(Suppl 1):107–20.CrossRefPubMedPubMedCentral
70.
Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010;105(7):1254–64.CrossRefPubMedPubMedCentral
71.
Latkin C, Yang C, Tobin K, Hulbert A. Factors associated with recruiting an HIV seropositive risk network member among injection drug users. Aids Behav. 2010;14(5):1137–41.CrossRefPubMedPubMedCentral
72.
Tyler K, Melander L. The effect of drug and sexual risk behaviours with social network and non-network members on homeless youths’ sexually transmissible infections and HIV testing. Sex Health. 2010;7(4):434–40.CrossRefPubMed
73.
Booth RE, Lehman WEK, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101(2):336–43.CrossRefPubMedPubMedCentral
74.
Davey-Rothwell MA, Chander G, Hester L, Latkin CA. Social network characteristics and heavy episodic drinking among women at risk for HIV/sexually transmitted infections. J Stud Alcohol. 2011;72(6):1041–7.CrossRef
75.
Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, Batluk J, Kozlov AA, Kozlov AP, Latkin CA. Unprotected sex in heterosexual partnerships of injecting drug users in st. Petersburg, Russia. AIDS Behav. 2011;15(1):58–64.CrossRefPubMedPubMedCentral
76.
Latkin C, Yang C, Srikrishnan AK, Solomon S, Mehta SH, Celentano DD, Kumar MS, Knowlton A, Solomon SS. The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India. Drug Alcohol Depend. 2011;117(1):50–4.CrossRefPubMedPubMedCentral
77.
Li J, Liu H, Li J, Luo J, Koram N, Detels R. Sexual transmissibility of HIV among opiate users with concurrent sexual partnerships: an egocentric network study in Yunnan, China. Addiction. 2011;106(10):1780–7; discussion 1788–9.
78.
Li J, Weeks MR, Borgatti SP, Clair S, Dickson-Gomez J. A social network approach to demonstrate the diffusion and change process of intervention from peer health advocates to the drug using community. Subst Use Misuse. 2012;47(5):474–90.CrossRefPubMedPubMedCentral
79.
Richardson L, Grund T. Modeling the impact of supra-structural network nodes: the case of anonymous syringe sharing and HIV among people who inject drugs. Soc Sci Res. 2012;41(3):624–36.CrossRefPubMed
80.
Smyrnov P, Broadhead RS, Datsenko O, Matiyash O. Rejuvenating harm reduction projects for injection drug users: Ukraine’s nationwide introduction of peer-driven interventions. Int J Drug Policy. 2012;23(2):141–7.CrossRefPubMed
81.
Adams J, Moody J, Morris M. Sex, drugs, and race: how behaviors differentially contribute to the sexually transmitted infection risk network structure. Am J Public Health. 2013;103(2):322–9.CrossRefPubMedPubMedCentral
82.
Brown RA, Kennedy DP, Tucker JS, Golinelli D, Wenzel SL. Monogamy on the street a mixed methods study of homeless men. J Mixed Methods Res. 2013;7(4):328–46.CrossRef
83.
Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, et al. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open. 2013;3(6):e002645.CrossRefPubMedPubMedCentral
84.
Green HD Jr, de la Haye K, Tucker JS, Golinelli D. Shared risk: who engages in substance use with American homeless youth? Addiction. 2013;108(9):1618–24.CrossRefPubMed
85.
Guo W, Bao SL, Lin W, Wu GH, Zhang W, Hladik W, et al. Estimating the size of HIV key affected populations in Chongqing, China, using the network scale-up method. PLoS One. 2013;8(8):e71796.CrossRefPubMedPubMedCentral
86.
Latkin C, Davey-Rothwell M, Yang JY, Crawford N. The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. J Urban Health. 2013;90(1):147–56.CrossRefPubMed
87.
Latkin C, Donnell D, Liu T-Y, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013;108(5):934–43.CrossRefPubMedPubMedCentral
88.
White K, Rudolph AE, Jones KC, Latkin C, Benjamin EO, Crawford ND, et al. Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/AIDS. AIDS Care. 2013;25(2):230–8.CrossRefPubMed
89.
Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D. Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2013;63:S90–4.CrossRef
90.
91.
Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57.PubMedPubMedCentral
92.
Latkin CA, Davey-Rothwell MA, Knowlton AR, Alexander KA, Williams CT, Boodram B. Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S54–8.CrossRefPubMedPubMedCentral
93.
De Cock KM, Crowley SP, Lo YR, Granich RM, Williams BG. Preventing HIV transmission with antiretrovirals. Bull World Health Organ. 2009;87(7):488–488A.CrossRefPubMedPubMedCentral
94.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.CrossRefPubMed
95.
Montaner JS. Treatment as prevention: toward an AIDS-free generation. Top Antivir Med. 2013;21(3):110–4.PubMed
96.
Broadhead RS, Borch C, Hulst YV, Gauchat G, Tehrani S, Stringer KL, et al. Relying on injection drug users to access and adhere to HIV therapeutics: bittersweet lessons using respondent-driven sampling and a peer-driven intervention. J Drug Issues. 2012;42(2):127–46.CrossRef
97.
98.
Simmons N, Donnell D, Ou SS, Celentano DD, Aramrattana A, Davis-Vogel A, et al. Assessment of contamination and misclassification biases in a randomized controlled trial of a social network peer education intervention to reduce HIV risk behaviors among drug users and risk partners in Philadelphia, PA and Chiang Mai, Thailand. AIDS Behav. 2015;19(10):1818–27.CrossRefPubMedPubMedCentral
99.
Anderson S, Allen P, Peckham S, Goodwin N. Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst. 2008;6:7.CrossRefPubMedPubMedCentral
100.
Metadata
Title
Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review
Authors
Debarchana Ghosh
Archana Krishnan
Britton Gibson
Shan-Estelle Brown
Carl A. Latkin
Frederick L. Altice
Publication date
01-04-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1413-y

Other articles of this Issue 4/2017

AIDS and Behavior 4/2017 Go to the issue

Editorial

Preventing HIV and Hepatitis Infections Among People Who Inject Drugs: Leveraging an Indiana Outbreak Response to Break the Impasse

Original Paper

The Relationship Between Methamphetamine Use, Sexual Sensation Seeking and Condomless Anal Intercourse Among Men Who Have Sex With Men in Vietnam: Results of a Community-Based, Cross-Sectional Study

Original Paper

Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort

Original Paper

A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO

Original Paper

Sexual Risk and Transmission Behaviors, Partnerships and Settings Among Young Adult Nonmedical Opioid Users in New York City

Original Article

Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits